ha 1004 has been researched along with lfm a13 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
Ellinger, B; Hübel, K; Koch, MA; Rauh, D; Triola, G; Waldmann, H; Wetzel, S | 1 |
2 other study(ies) available for ha 1004 and lfm a13
Article | Year |
---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffolds.
Topics: Adenosine Triphosphate; Amides; Anti-Bacterial Agents; Binding Sites; Isoxazoles; Leflunomide; Nitriles; Peptide Synthases; Protein Kinase Inhibitors; Salicylates; Structure-Activity Relationship | 2009 |